AXB

70.3

+1.01%↑

BRKB

507.26

+0.81%↑

BRKA.US

760,670

+0.82%↑

JPM

267.37

+0.52%↑

V

362.39

+1.63%↑

AXB

70.3

+1.01%↑

BRKB

507.26

+0.81%↑

BRKA.US

760,670

+0.82%↑

JPM

267.37

+0.52%↑

V

362.39

+1.63%↑

AXB

70.3

+1.01%↑

BRKB

507.26

+0.81%↑

BRKA.US

760,670

+0.82%↑

JPM

267.37

+0.52%↑

V

362.39

+1.63%↑

AXB

70.3

+1.01%↑

BRKB

507.26

+0.81%↑

BRKA.US

760,670

+0.82%↑

JPM

267.37

+0.52%↑

V

362.39

+1.63%↑

AXB

70.3

+1.01%↑

BRKB

507.26

+0.81%↑

BRKA.US

760,670

+0.82%↑

JPM

267.37

+0.52%↑

V

362.39

+1.63%↑

Search

Walker & Dunlop Inc

Uždarymo kaina

SektoriusFinansų sektorius

73.4 -0.85

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

72.39

Max

74.03

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-38M

2.8M

Pardavimai

-104M

237M

P/E

Sektoriaus vid.

26.014

24.598

Pelnas, tenkantis vienai akcijai

0.85

Dividendų pajamingumas

3.78

Pelno marža

1.16

Darbuotojai

1,394

EBITDA

-25M

79M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+35.1% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.78%

4.30%

Kitas uždarbis

2025-08-07

Kitas dividendų mokėjimo data

2025-05-29

Kita Ex Dividend data

2025-05-15

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-323M

2.6B

Ankstesnė atidarymo kaina

74.25

Ankstesnė uždarymo kaina

73.4

Naujienos nuotaikos

By Acuity

25%

75%

62 / 540 reitingas Finance

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Walker & Dunlop Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-05-14 23:40; UTC

Karštos akcijos

Stocks to Watch: UnitedHealth Group, Foot Locker, CoreWeave

2025-05-14 23:33; UTC

Pagrindinės rinkos jėgos

UnitedHealth Group Shares Fall After WSJ Reports of Investigation for Possible Medicare Fraud

2025-05-14 23:25; UTC

Pagrindinės rinkos jėgos

Biohaven Shares Down as FDA Extends PDUFA Data for Troriluzole

2025-05-14 23:25; UTC

Uždarbis

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth -- Update

2025-05-14 22:58; UTC

Uždarbis

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth

2025-05-14 21:35; UTC

Uždarbis

Cisco Systems Names Patterson as CFO, Patel as President

2025-05-14 23:59; UTC

Rinkos pokalbiai

Implications of Xero's Cost Outlook Aren't Clear -- Market Talk

2025-05-14 23:49; UTC

Rinkos pokalbiai

Xero's Cost Outlook Likely to Prompt Downgrades -- Market Talk

2025-05-14 23:48; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-05-14 23:48; UTC

Rinkos pokalbiai

Nikkei May Decline on Profit-Taking After Recent Gains -- Market Talk

2025-05-14 23:47; UTC

Rinkos pokalbiai

Gold Gains on Possible Technical Recovery -- Market Talk

2025-05-14 23:34; UTC

Įsigijimai, susijungimai, perėmimai

Agnico-Eagle Mines to Subscribe for 30M Voting Common Shares of Foran Mining in Non-Brokered Private Placement at C$3 a Share

2025-05-14 23:10; UTC

Uždarbis

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth -- Update

2025-05-14 23:07; UTC

Uždarbis

CoreWeave Posts Strong Revenue and Wins Google as a Customer. Stock Still Dives on Outlook. -- Barrons.com

2025-05-14 23:00; UTC

Svarbiausios naujienos

UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud -- WSJ

2025-05-14 22:43; UTC

Uždarbis

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth

2025-05-14 22:34; UTC

Uždarbis

Xero Expects 1H Operating Expense Ratio to Be Higher Than 2H>XRO.AU

2025-05-14 22:33; UTC

Uždarbis

Xero Expects FY26 Operating Expense Ratio of 71.5%>XRO.AU

2025-05-14 22:30; UTC

Uždarbis

Xero Did Not Declare a Dividend>XRO.AU

2025-05-14 22:30; UTC

Uždarbis

Xero FY Operating Expenses 71.8% of Operating Revenue Vs. 73.3%>XRO.AU

2025-05-14 22:30; UTC

Uždarbis

Xero FY Free Cashflow Margin 24.1% Vs. 20.0%>XRO.AU

2025-05-14 22:30; UTC

Uždarbis

Xero FY Free Cashflow NZD506.7M Vs. NZD342.1M>XRO.AU

2025-05-14 22:28; UTC

Uždarbis

Xero FY Ebitda NZD638.5M Vs. NZD497.4M>XRO.AU

2025-05-14 22:28; UTC

Uždarbis

Xero FY Adjusted Ebitda NZD640.6M Vs. NZD526.5M>XRO.AU

2025-05-14 22:27; UTC

Uždarbis

Xero FY Rev NZD2.10B Vs. NZD1.71B >XRO.AU

2025-05-14 22:27; UTC

Uždarbis

Xero FY Net NZD227.8M Vs. Net NZD174.6M >XRO.AU

2025-05-14 22:23; UTC

Svarbiausios naujienos

Boeing, GE Aerospace Get Qatar Airways Order After Saudi AI Tech Deals -- 2nd Update

2025-05-14 22:15; UTC

Uždarbis

Correction to Cisco Earnings Article -- WSJ

2025-05-14 21:48; UTC

Uždarbis

CoreWeave Posts Strong Revenue but Stock Dives on Updated Outlook -- Barrons.com

2025-05-14 21:37; UTC

Uždarbis

Cisco Reports Solid Earnings. The Stock Is Rising. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Walker & Dunlop Inc Prognozė

Kainos tikslas

By TipRanks

35.1% į viršų

12 mėnesių prognozė

Vidutinis 100 USD  35.1%

Aukščiausias 105 USD

Žemiausias 95 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Walker & Dunlop Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

1

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

70.995 / 76.69Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

No Evidence

Rinkos nuotaikos

By Acuity

62 / 540 reitingas Finansų sektorius

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Walker & Dunlop Inc

Walker & Dunlop, Inc. is a holding company, which conducts its operations through Walker & Dunlop, LLC. The Company provides commercial real estate and financial services. It originates, sells, and services a range of commercial real estate debt and equity financing products and provides multifamily property sales brokerage and valuation services. It is also engaged in commercial real estate investment management activities. The Company provides housing market research and delivers real estate-related investment banking and advisory services. Through its agency products, the Company originates and sells loans pursuant to the programs of the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Federal Housing Administration. Through its debt brokerage products, the Company brokers, and in some cases services, loans for various life insurance companies, commercial banks, commercial mortgage-backed securities issuers and other institutional investors.